中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
13期
101-103
,共3页
血液透析%尿毒症脑病%临床特点
血液透析%尿毒癥腦病%臨床特點
혈액투석%뇨독증뇌병%림상특점
Hemodialysis%Uremia encephalopathy%Clinical characteristics
目的：探讨并分析血液透析合并血液灌流对尿毒症脑病患者的治疗效果，为今后的临床诊疗方法提供可靠性的参考依据。方法回顾性分析来该院进行诊疗的60例尿毒症患者，并随机分为单纯采用血液透析治疗的对照组和采用血液透析加血液灌流的观察组，详细记录两组患者的临床至于效果以及随访6个月内的复发情况和生活质量。结果观察组患者的临床治疗总有效率为96.7%，其中痊愈患者有8例，而对照组患者的临床总有效率为63.4%，痊愈患者只有2例，两组相比，差异具有统计学意义(P<0.01)。将两组患者分别进行治疗前后的比较，除对照组在β2-MG上无变化外(P>0.05)，其余均出现下降趋势，且差异有统计学意义(P<0.05)。结论血液透析合并血液灌流对尿毒症患者具有很好的临床治疗效果，不仅可以增强血液透析对中、大分子尿毒物质的清除能力，还可以增加血液灌流的作用面积，故值得临床上进一步推广与使用。
目的：探討併分析血液透析閤併血液灌流對尿毒癥腦病患者的治療效果，為今後的臨床診療方法提供可靠性的參攷依據。方法迴顧性分析來該院進行診療的60例尿毒癥患者，併隨機分為單純採用血液透析治療的對照組和採用血液透析加血液灌流的觀察組，詳細記錄兩組患者的臨床至于效果以及隨訪6箇月內的複髮情況和生活質量。結果觀察組患者的臨床治療總有效率為96.7%，其中痊愈患者有8例，而對照組患者的臨床總有效率為63.4%，痊愈患者隻有2例，兩組相比，差異具有統計學意義(P<0.01)。將兩組患者分彆進行治療前後的比較，除對照組在β2-MG上無變化外(P>0.05)，其餘均齣現下降趨勢，且差異有統計學意義(P<0.05)。結論血液透析閤併血液灌流對尿毒癥患者具有很好的臨床治療效果，不僅可以增彊血液透析對中、大分子尿毒物質的清除能力，還可以增加血液灌流的作用麵積，故值得臨床上進一步推廣與使用。
목적：탐토병분석혈액투석합병혈액관류대뇨독증뇌병환자적치료효과，위금후적림상진료방법제공가고성적삼고의거。방법회고성분석래해원진행진료적60례뇨독증환자，병수궤분위단순채용혈액투석치료적대조조화채용혈액투석가혈액관류적관찰조，상세기록량조환자적림상지우효과이급수방6개월내적복발정황화생활질량。결과관찰조환자적림상치료총유효솔위96.7%，기중전유환자유8례，이대조조환자적림상총유효솔위63.4%，전유환자지유2례，량조상비，차이구유통계학의의(P<0.01)。장량조환자분별진행치료전후적비교，제대조조재β2-MG상무변화외(P>0.05)，기여균출현하강추세，차차이유통계학의의(P<0.05)。결론혈액투석합병혈액관류대뇨독증환자구유흔호적림상치료효과，불부가이증강혈액투석대중、대분자뇨독물질적청제능력，환가이증가혈액관류적작용면적，고치득림상상진일보추엄여사용。
Objective Observation and analysis of hemodialysis combined with hemoperfusion on patients with uremic en-cephalopathy treatment effect, to provide reference for clinical diagnosis and treatment of the reliability of the method in the future. Methods Randomly selected 30 cases of uremia patients came to our hospital for diagnosis and treatment, according to single and double its bed is divided into the simple use of the control group treatment of hemodialysis and hemoperfusion with hemodial-ysis and the observation group, a detailed record of two groups of patients for clinical effect and within 6 months of follow-up re-currence rate and quality of life. Results Clinical observation of the patients in the treatment group the total effective rate was 93.3%, in which the patient cured 8 cases, while the control group of patients with clinical total effective rate was 80%, cure pa-tients only in 2 cases, the two groups were compared(P<0.01), there is a statistically significant difference. The two groups of pa-tients were compared before and after treatment, in addition to the control group in the beta 2-MG no change (P>0.05), the rest are declining trend, and there were significant differences in (P<0.05). Conclusion Hemodialysis combined with hemoperfusion has very good clinical therapeutic effect in patients with uremia, can not only enhance the scavenging ability on hemodialysis in ure-mic, macromolecular material, also can increase the effect of hemoperfusion in the area, it is worthy of further promotion and use.
